Piramal Pharma Ltd. To Invest Minority Stake in Yapan Bio, India-Based CDMO Providing Expertise in Biologics and Vaccines
Summary
Atin Tomar and Nirav Desai, CEO and COO of Yapan, said, "We are very excited about this transaction and are confident that PPS is the ideal partner to take the business through its next phase of growth. Yapans employees and customers, who are the core stakeholders of our business, will most assuredly benefit from PPS expertise in providing integrated services on a global scale." Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovator and generic companies. Yapan Bio Pvt Ltd, located in Genome Valley in Hyderabad, has been founded by Atin Tomar and Nirav Desai, both having ~40 years of combined experience in the biotechnology industry, globally, specializing in the fields of development, manufacturing and commercialization of Vaccines and Biologics/Bio-therapeutics.